IQVIA (NYSE:IQV) Shares Sold by Rep. Kevin Hern

Key Points

• Rep. Kevin Hern sold IQVIA shares worth between $1,001 and $15,000 on September 3 from the Kaden Everett Hern Trust account. He also disclosed multiple sales of other holdings, including an additional $15,001–$50,000 IQVIA sale on September 14.
• IQVIA reported quarterly EPS of $3.15 and revenue of $4.37 billion, beating analyst estimates, while revenue increased 8.7% year over year. The company set fiscal 2026 EPS guidance at $12.80–$13.00.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $253.25; recent targets range as high as $329. Insiders have sold 15,581 shares worth approximately $3.8 million over the past three months.

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of IQVIA Holdings Inc. NYSE: IQV. In a filing disclosed on September 25th, the Representative disclosed that they had sold between $1,001 and $15,000 in IQVIA stock on September 3rd. The trade occurred in the Representative's "KADEN EVERETT HERN TRUST" account.

Representative Kevin Hern also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of CenterPoint Energy NYSE: CNP on 9/15/2026.
• Sold $1,001 - $15,000 in shares of TJX Companies NYSE: TJX on 9/15/2026.
• Sold $15,001 - $50,000 in shares of STERIS NYSE: STE on 9/15/2026.
• Sold $1,001 - $15,000 in shares of Seagate Technology NASDAQ: STX on 9/15/2026.
• Sold $15,001 - $50,000 in shares of NextEra Energy NYSE: NEE on 9/14/2026.
• Sold $1,001 - $15,000 in shares of Marsh & McLennan Companies NYSE: MRSH on 9/14/2026.
• Sold $15,001 - $50,000 in shares of IQVIA NYSE: IQV on 9/14/2026.
• Sold $15,001 - $50,000 in shares of Home Depot NYSE: HD on 9/14/2026.
• Sold $1,001 - $15,000 in shares of Home Depot NYSE: HD on 9/14/2026.
• Sold $15,001 - $50,000 in shares of Emerson Electric NYSE: EMR on 9/14/2026.

IQVIA Stock Performance

IQV opened at $271.01 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 2.18. The stock's 50 day moving average price is $250.32 and its two-hundred day moving average price is $203.63. The firm has a market capitalization of $44.61 billion, a P/E ratio of 33.62, a price-to-earnings-growth ratio of 2.31 and a beta of 1.18. IQVIA Holdings Inc. has a 12-month low of $154.50 and a 12-month high of $277.40.

IQVIA (NYSE:IQV - Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The medical research company reported $3.15 EPS for the quarter, topping analysts' consensus estimates of $3.03 by $0.12. The company had revenue of $4.37 billion during the quarter, compared to analyst estimates of $4.30 billion. IQVIA had a return on equity of 30.25% and a net margin of 8.10%.The company's quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the company earned $2.81 earnings per share. IQVIA has set its FY 2026 guidance at 12.800-13.000 EPS. On average, equities analysts forecast that IQVIA Holdings Inc. will post 11.56 earnings per share for the current year.

Insider Activity

In other news, insider W. Richard Staub sold 5,500 shares of the firm's stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $232.68, for a total transaction of $1,279,740.00. Following the completion of the sale, the insider owned 13,312 shares of the company's stock, valued at approximately $3,097,436.16. This trade represents a 29.24% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Eric Sherbet sold 5,000 shares of IQVIA stock in a transaction that occurred on Wednesday, July 29th. The shares were sold at an average price of $249.16, for a total transaction of $1,245,800.00. Following the completion of the transaction, the insider owned 20,999 shares of the company's stock, valued at $5,232,110.84. This trade represents a 19.23% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 15,581 shares of company stock valued at $3,796,021. Corporate insiders own 1.70% of the company's stock.

Analysts Set New Price Targets

Several research firms recently commented on IQV. Mizuho upped their target price on shares of IQVIA from $215.00 to $230.00 and gave the company an "outperform" rating in a research note on Monday, July 13th. BMO Capital Markets boosted their price objective on shares of IQVIA from $210.00 to $270.00 and gave the stock an "outperform" rating in a report on Wednesday, July 29th. Stifel Nicolaus upped their price objective on shares of IQVIA from $220.00 to $276.00 and gave the company a "buy" rating in a research report on Wednesday, July 29th. Truist Financial reissued a "buy" rating and set a $329.00 target price (up from $300.00) on shares of IQVIA in a research report on Monday. Finally, Weiss Ratings upgraded IQVIA from a "hold (c)" rating to a "hold (c+)" rating in a research note on Thursday. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, IQVIA currently has a consensus rating of "Moderate Buy" and an average price target of $253.25.

Hedge Funds Weigh In On IQVIA

Hedge funds and other institutional investors have recently made changes to their positions in the business. QRG Capital Management Inc. raised its position in IQVIA by 87.7% in the second quarter. QRG Capital Management Inc. now owns 58,407 shares of the medical research company's stock worth $11,285,000 after purchasing an additional 27,283 shares in the last quarter. Envestnet Portfolio Solutions Inc. lifted its holdings in shares of IQVIA by 3.7% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 4,872 shares of the medical research company's stock valued at $941,000 after acquiring an additional 174 shares during the period. National Pension Service boosted its stake in shares of IQVIA by 6.6% in the 2nd quarter. National Pension Service now owns 375,973 shares of the medical research company's stock valued at $72,646,000 after purchasing an additional 23,411 shares in the last quarter. WINTON GROUP Ltd acquired a new stake in shares of IQVIA during the 2nd quarter worth about $5,046,000. Finally, Engineers Gate Manager LP bought a new position in IQVIA during the 2nd quarter valued at about $632,000. 89.62% of the stock is owned by institutional investors.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma's 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027. Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma's 1st Congressional District. He declared candidacy for the 2026 election. Kevin Hern went into business as a McDonald's franchisee in 1999. He acquired 10 McDonald's franchises by 2012. He served on the McDonald's National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

About IQVIA

IQVIA Holdings Inc is a global provider of advanced analytics, technology solutions and contract research services for the life sciences industry. The company supports pharmaceutical, biotechnology and medical device companies throughout the product life cycle, from research and clinical development through commercialization and post-market activities.

Its offerings include clinical trial management, site and patient services, real-world evidence, healthcare data, regulatory and safety services, commercial analytics, consulting, and technology platforms.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.